New pharmacotherapies for alcohol dependence: Are they being used and what do they cost?

Medical Journal of Australia

Volumn 179, Issue 4, 2003, Pages 218-

  Doran, Christopher M ^a   Fawcett, Julia E ^a   Shakeshaft, Anthony P ^a   Shanahan, Marian D ^a   Mattick, Richard P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACAMPROSATE; BENZODIAZEPINE; DIAZEPAM; DISULFIRAM; NALTREXONE;

ALCOHOL WITHDRAWAL; ALCOHOLISM; AUSTRALIA; DRUG COST; DRUG MARKETING; DRUG UTILIZATION; GENERAL PRACTITIONER; HUMAN; LETTER; PATIENT COMPLIANCE; RELAPSE;

EID: 0042427422     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2003.tb05506.x     Document Type: Letter

References (6)

1. Hall W, Teeson M, Lynsky M, Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Well-Being. Addiction 1999; 94: 1541-1550.
2. Mattick RP, Jarvis T. An Outline for the Management of Alcohol Problems: Quality Assurance in the Treatment of Drug Dependence Project. Canberra: Commonwealth Department of Human Services and Health, 1993. (Monograph no. 20.)
3. Health Insurance Commission. Pharmaceutical benefits schedule items statistics. Available at: www.hic.gov.au/statistics/dyn_pbs/forms/pbs_tab1.shtml (accessed Apr 2003).
4. MIMS Australia. MIMS Annual. 26th ed. Sydney: Medi Media Australia, 2002.
5. Australian Department of Health and Ageing. Schedule of Pharmaceutical Benefits for Approved Pharmacists and Medical Practitioners. Canberra: The Department, 2001.
6. Australian Department of Health and Ageing. Medicare statistics. March quarter 2003. Table B6. Average patient contribution per service (patient and bulk billed services out-of-hospital only). Available at: www.health.gov.au/haf/medstats/index.pdf (accessed Jul 2003).